- 5 Risultati
prezzo più basso: € 123,43, prezzo più alto: € 251,15, prezzo medio: € 178,84
1
Opiate Receptors and Antagonists: From Bench to Clinic - Reginald Dean
Ordina
da ZVAB.com
CHF 143,95
(indicativi € 150,51)
Spedizione: € 18,191
OrdinaLink sponsorizzato
Reginald Dean:

Opiate Receptors and Antagonists: From Bench to Clinic - edizione con copertina flessibile

2010, ISBN: 1617378224

[EAN: 9781617378225], Libro nuovo, [SC: 18.19], [PU: SPRINGER NATURE], MEDICAL / NURSING; PHARMACOLOGY, Druck auf Anfrage Neuware - Printed after ordering - Comprehensive and authoritativ… Altro …

NEW BOOK. Costi di spedizione: EUR 18.19 AHA-BUCH GmbH, Einbeck, Germany [51283250] [Rating: 5 (su 5)]
2
Opiate Receptors and Antagonists: From Bench to Clinic (Contemporary Neuroscience)
Ordina
da amazon.co.uk
£ 107,81
(indicativi € 123,43)
Spedizione: € 5,501
OrdinaLink sponsorizzato
Opiate Receptors and Antagonists: From Bench to Clinic (Contemporary Neuroscience) - edizione con copertina flessibile

2010, ISBN: 9781617378225

Editor: Dean, Reginald, Editor: Bilsky, Edward J. Editor: Negus, S. Stevens, Humana, Paperback, Auflage: Softcover reprint of hardcover 1st ed. 2009, 780 Seiten, Publiziert: 2010-11-19T00… Altro …

Costi di spedizione:Le spese di spedizione possono differire dai costi effettivi. (EUR 5.50)
3
Ordina
da AbeBooks.it
CHF 186,75
(indicativi € 195,26)
Spedizione: € 45,111
OrdinaLink sponsorizzato
Bilsky, Edward J.:
Opiate Receptors and Antagonists: From Bench to Clinic (Contemporary Neuroscience) - edizione con copertina flessibile

2010

ISBN: 1617378224

[EAN: 9781617378225], Libro nuovo, [SC: 45.11], [PU: Humana], Clean and crisp and new!, Books

NEW BOOK. Costi di spedizione: EUR 45.11 Welcome Back Books, Toledo, OH, U.S.A. [64434632] [Rating: 4 (su 5)]
4
Ordina
da AbeBooks.it
CHF 164,48
(indicativi € 173,85)
Spedizione: € 84,641
OrdinaLink sponsorizzato
Opiate Receptors and Antagonists: From Bench to Clinic (Contemporary Neuroscience) - edizione con copertina flessibile

2010, ISBN: 1617378224

[EAN: 9781617378225], Libro nuovo, [SC: 84.64], [PU: Humana], Books

NEW BOOK. Costi di spedizione: EUR 84.64 Lucky's Textbooks, Dallas, TX, U.S.A. [60577173] [Rating: 5 (su 5)]
5
Opiate Receptors and Antagonists: From Bench to Clinic - Collectif
Ordina
da Rakuten.fr
€ 251,15
Spedizione: € 0,001
OrdinaLink sponsorizzato
Collectif:
Opiate Receptors and Antagonists: From Bench to Clinic - libri usati

ISBN: 9781617378225

Livre

1 Offers. Costi di spedizione:France. (EUR 0.00) Priceminister

1Poiché alcune piattaforme non trasmettono le condizioni di spedizione e queste possono dipendere dal paese di consegna, dal prezzo di acquisto, dal peso e dalle dimensioni dell'articolo, dall'eventuale iscrizione alla piattaforma, dalla consegna diretta da parte della piattaforma o tramite un fornitore terzo (Marketplace), ecc. è possibile che le spese di spedizione indicate da eurolibro non corrispondano a quelle della piattaforma offerente.

Dati bibliografici del miglior libro corrispondente

Dettagli del libro
Opiate Receptors and Antagonists: From Bench to Clinic (Contemporary Neuroscience)

Comprehensive and authoritative, Opioid Receptors and Antagonists: From Bench to Clinic offers neuroscientists, pharmacologists and interested clinicians a unique survey of the extensive and diverse research efforts currently employed with opioid antagonists to develop novel innovative drug therapies. Summarizes the present understanding of the chemistry, pharmacology and molecular biology of opioid receptors and their subtypes Highlights differences and similarities between the opioid pharmacology of animals and human Describes current and potential therapeutic areas for opioid antagonists, including substance abuse, alcohol and ingestive behaviors, behavioral disorders and other medical indications, supported by nonclinical and clinical evidence Focuses on the development of exciting and innovative drug delivery approaches that are being used with opioid antagonists for the above medical indications

Informazioni dettagliate del libro - Opiate Receptors and Antagonists: From Bench to Clinic (Contemporary Neuroscience)


EAN (ISBN-13): 9781617378225
ISBN (ISBN-10): 1617378224
Copertina rigida
Copertina flessibile
Anno di pubblicazione: 2010
Editore: Humana
523 Pagine
Peso: 1,129 kg
Lingua: eng/Englisch

Libro nella banca dati dal 2012-07-14T07:32:32+02:00 (Zurich)
Pagina di dettaglio ultima modifica in 2023-10-31T10:42:37+01:00 (Zurich)
ISBN/EAN: 9781617378225

ISBN - Stili di scrittura alternativi:
1-61737-822-4, 978-1-61737-822-5
Stili di scrittura alternativi e concetti di ricerca simili:
Titolo del libro: opiate receptors and antagonists from bench clinic


Dati dell'editore

Autore: Reginald Dean; Edward J. Bilsky; S. Stevens Negus
Titolo: Contemporary Neuroscience; Opiate Receptors and Antagonists - From Bench to Clinic
Editore: Humana; Humana Press
757 Pagine
Anno di pubblicazione: 2010-11-19
Totowa; NJ; US
Stampato / Fatto in
Peso: 1,132 kg
Lingua: Inglese
160,49 € (DE)
164,99 € (AT)
177,00 CHF (CH)
POD
XXIII, 757 p.

BC; Pharmacology/Toxicology; Hardcover, Softcover / Medizin/Pharmazie; Pharmakologie; Verstehen; Antag; Antagonists; Bench; Clinic; Contemporary; Dean; Ethanol; Neuroscience; Opiate; Opioid; Receptors; marijuana; Pharmacology; BB

OPIOID RECEPTORS.- Ultra-Low Dose Opioid Antagonists Enhance Opioid Analgesia and Reduce Tolerance.- Upregulation of Opioid Receptors.- Imaging Human Brain Opioid Receptors: Applications to Substance Use Disorders.- Opioid Receptor Antagonists-Mediated Signaling in Immune System.- OPIOID ANTAGONISTS: CHEMISTRY AND PHARMACOLOGY.- The Chemistry and Pharmacology of Mu Opioid Antagonists.- Medicinal Chemistry of Kappa Antagonists.- The Pharmacology of Delta Opioid Antagonists.- Novel Opioid Antagonists with Mixed/Dual Selectivity.- Experimental Utility and Clinical Potential of Irreversible Opioid Antagonists.- Methylnaltrexone: A Peripherally Acting Opioid Antagonist.- SUBSTANCE ABUSE.- Opioid Antagonist Effects in Animal Models Related to Opioid Abuse: Drug Discrimination and Drug Self-Administration.- Naltrexone for Initiation and Maintenance of Opiate Abstinence.- Ultra-Low Dose Naltrexone Decreases Dependence and Addictive Properties of Opioids.- Can a Combination Formulation Containing a Neutral Opiate Antagonist Decrease the Abuse of µ-Agonist Opiates?.- Effects of Opioid Antagonists on the Abuse-Related Effects of Psychomotor Stimulants and Nicotine.- Potential Use of Opioid Antagonists in the Treatment of Marijuana Abuse and Dependence.- Naltrexone in Smoking Cessation: A Review of the Literature and Future Directions.- ALCOHOL AND INGESTIVE BEHAVIORS.- Opioid Antagonists and Ethanol’s Ability to Reinforce Intake of Alcoholic Beverages: Preclinical Studies.- Clinical Use of Opioid Antagonists in the Treatment of Alcohol Dependence.- Preclinical Effects of Opioid Antagonists on Feeding and Appetite.- CNS Opiate Systems and Eating Disorders.- BEHAVIORAL DISORDERS.- Potential Utility of Kappa Ligands in the Treatment of Mood Disorders.- Opioid Antagonists in the Treatment of Pathological Gambling and Kleptomania.- Efficacy of Opioid Antagonists in Attenuating Self-Injurious Behavior.- Pharmacotherapeutic Effects of OpioidAntagonists in Alcohol Abusing Patients with Schizophrenia.- MEDICAL INDICATIONS.- Current Issues in the Use of Opioid Antagonists.- Emergency Room Use of Opioid Antagonists in Drug Intoxication and Overdose.- Kappa Opioid Antagonists as Pruritogenic Agents.- Clinical Effect of Opioid Antagonists on Clinical Pruritus.- Effects of Opioid Antagonists on L-Dopa-Induced Dyskinesia in Parkinson’s Disease.- Endocrine Effects of Opioid Antagonists.- Opioid Antagonists in Traumatic Shock: Animal and Human Studies.- The Efficac y of Opioid Antagonists against Heatstroke-Induced Ischemia and Injury in Rats.- A Review of the Opioid System in Cancer Patients and Preliminary Results of Opioid Antagonists in the Treatment of Human Neoplasm.- DRUG DELIVERY APPROACHES.- Non-Clinical Pharmacology of VIVITROL®: A Monthly Injectable Naltrexone for the Treatment of Alcohol Dependence.- The Development of Sustained Release Naltrexone and Clinical Use in Treating Opiate Dependency.- The Development of Proneura Technology for the Treatment of Addictions.- Development of Opioid Transdermal Delivery Systems.- Intranasal Naloxone for Treatment of Opioid Overdose.

< Per archiviare...